Serum sickness in children after antibiotic exposure: estimates of occurrence and morbidity in a health maintenance organization population

American Journal of Epidemiology
S R HeckbertR Platt

Abstract

The computerized outpatient records of the Harvard Community Health Plan, a 230,000-member health maintenance organization, were used to determine the frequency with which serum sickness is recognized in the practice setting after exposure to antibiotics. The medical records of 3,487 children who had been prescribed cefaclor or amoxicillin were searched in December 1986 for coded diagnoses of serum sickness and related conditions. Diagnoses were validated by blinded review of dictated and written office notes. There were 12 cases of serum sickness in 11,523 child-years. During this time, these children were prescribed 13,487 courses of amoxicillin, 5,597 courses of trimethoprim-sulfamethoxazole (TMP-SMZ), 3,553 courses of cefaclor, and 2,325 courses of penicillin V. Serum sickness was considered to be antibiotic-related if it occurred within 20 days of initiation of antibiotic therapy. Five cases were temporally associated with cefaclor, one with both amoxicillin and TMP-SMZ, four with TMP-SMZ alone, and one with penicillin V alone. One case was not associated with any antibiotic exposure. All antibiotic-related cases occurred in children under age 6 years who were treated for otitis media or streptococcal pharyngitis, and most...Continue Reading

Citations

Nov 25, 1998·Pediatric Annals·K Y KwongC A Jones
Jul 1, 1992·The Annals of Pharmacotherapy·T VialJ Descotes
Feb 1, 1997·The Pediatric Infectious Disease Journal·G L Darmstadt
Jul 24, 1998·Postgraduate Medicine·M S DaoudC H Dicken
Feb 6, 2009·The Annals of Pharmacotherapy·Sadia Ashraf-BensonLisa A Veach
Sep 9, 2015·American Journal of Health-system Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists·David J Snyder, F Bahar Matusik
Nov 7, 2019·Current Pharmaceutical Design·Aslı GelincikSemanur Kuyucu
Mar 1, 1993·Pediatric Annals·M A Del Beccaro
Dec 1, 1993·The Journal of Legal Medicine·S Loue
Jun 1, 2000·Clinical Reviews in Allergy & Immunology·P Wolkenstein, J Revuz
May 25, 2006·Pharmacotherapy·Brychan M ClarkNicholas G Conger
Mar 23, 2011·Drug Metabolism and Drug Interactions·Fatih Mehmet AzikTalia Ileri
Jun 3, 2014·BMC Health Services Research·Natalie J ShiffLisa M Lix
Sep 30, 2015·Allergy·Eva GomesUNKNOWN ENDA/EAACI Drug Allergy Interest Group
Nov 10, 1994·The New England Journal of Medicine·J C Roujeau, R S Stern
May 2, 2001·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·S KnowlesN H Shear
Mar 18, 2011·Dermatologic Therapy·Robert Micheletti, Misha Rosenbach
May 27, 2003·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Edward D RalphAnne Marie Bombassaro
Mar 1, 2003·Clinics in Dermatology·James Q Del Rosso
May 2, 2021·Pediatric Allergy and Immunology : Official Publication of the European Society of Pediatric Allergy and Immunology·Natalia Blanca-LopezJean-Christoph Caubet
Sep 1, 1994·The Journal of Emergency Medicine·J A Kline, J W Runge
Apr 14, 2007·Dermatologic Clinics·Sandra R Knowles, Neil H Shear
Oct 3, 2007·Pediatrics·Alissa R SegalBarrett Zlotoff

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.